The ZAMASA Foundation is a research foundation focused specifically on leading edge research into multiple myeloma, with an emphasis on recent genetically engineered advances in immunotherapy. The Foundation will also focus on the advancement of genetic approaches to treatments that are focused on some of the more debilitating aspects associated with disease progression (such as bone and kidney damage). Initiatives targeting more effective early screening of multiple myeloma may also be considered.

Through collaboration and direct funding the ZAMASA Foundation will contribute to ongoing global efforts to provide patients with longevity and enhanced quality of life.

The ZAMASA Foundation will look to advance immunotherapy research as it applies to multiple myeloma through a variety of means, including:

Through the continued rapid advancement of immunotherapies the ZAMASA Foundation envisions a world where multiple myeloma is either curable or manageable as a long term chronic condition.

    Join our mailing list

    If you are interested in learning more about the ZAMASA Foundation please contact us



    Be part of the solution